Concepedia

Nisha Nanda

NN

Statistics

Publications

17

Citations

1.7K

H-Index

14

Active since

2000

Affiliations

Victor Chang Cardiac Research Institute(Current)

Portola Pharmaceuticals (United States)

The University of Texas MD Anderson Cancer Center

University of Colorado Denver

Nisha Nanda is an author at Victor Chang Cardiac Research Institute specializing in medicine, oncology, and pathology.

Top concepts

MedicineOncologyPathologyCell BiologyCancer TherapyCancer ResearchRadiation OncologyPharmacologyTumor BiologyClinical Safety

Publications per year

2000–2017

17

Publications

17

An Oncogenic <i>NTRK</i> Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

Robert C. Doebele, Lara E. Davis, Aria Vaishnavi et al. · Cancer Discovery · 2015 · 385 citations · Full text

Targeted Inactivation of Gh/Tissue Transglutaminase II

Nisha Nanda, Siiri E. Iismaa, W. Andrew Owens et al. · Journal of Biological Chemistry · 2001 · 290 citations · Full text

Platelet Endothelial Aggregation Receptor 1 (PEAR1), a Novel Epidermal Growth Factor Repeat-containing Transmembrane Receptor, Participates in Platelet Contact-induced Activation

Nisha Nanda, Ming Bao, Hanna Lin et al. · Journal of Biological Chemistry · 2005 · 145 citations · Full text

Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation

Jörge E. Cortes, Jeff H. Lipton, Delphine Réa et al. · Blood · 2012 · 135 citations · Full text

PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model

Michael P. Reilly, Uma Sinha, Pierrette André et al. · Blood · 2010 · 131 citations · Full text

1–5 of 17